Fulcrum Therapeutics (FULC) executive compensation, 2026 proxy

Alex C. Sapir, President and Chief Executive Officer, was paid $3.3M in 2025, up 224% from $1M the year before.

Filed
April 30, 2026
Annual meeting
June 24, 2026
Pay year
2025
Named executives
3
CEO total pay
$3.3M+224% vs prior year
CEO 2025 Total Pay
$3,251,490Significant increase over prior year
CEO Target Bonus Percentage
55%Expressed as percentage of salary
Bonus Payout Percentage
115%Based on holistic performance review

How Sapir was paid

$3.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary20%Option awards63%Non-equity incentive13%All other compensation4%

Named executive officers

ExecutiveTotal
Alex C. SapirPresident and Chief Executive Officer$3,251,490
Alan MussoChief Financial Officer$1,807,125
Curtis OltmansChief Legal Officer and Head of External Affairs$1,482,850

What changed and why

  • $3.3MAlex C. Sapir received total compensation of $3,251,490 in fiscal 2025, an increase from $1,003,300 in fiscal 2024.
  • 115%Named executive officer performance bonuses were paid at 115% of target based on corporate performance goals.
  • Option awards were granted to executives as long-term incentives to align with shareholder interests.
  • Base salaries for named executive officers were increased for fiscal 2026.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.